Graphene & Solar Technologies Ltd Quarterly Interest Expense in USD from Q3 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Graphene & Solar Technologies Ltd quarterly/annual Interest Expense history and growth rate from Q3 2010 to Q1 2024.
  • Graphene & Solar Technologies Ltd Interest Expense for the quarter ending March 31, 2024 was $12.7K, a 153% increase year-over-year.
  • Graphene & Solar Technologies Ltd Interest Expense for the twelve months ending March 31, 2024 was $35.8K, a 79.5% increase year-over-year.
  • Graphene & Solar Technologies Ltd annual Interest Expense for 2023 was $23.2K, a 34.1% decline from 2022.
  • Graphene & Solar Technologies Ltd annual Interest Expense for 2022 was $35.3K, a 76.7% decline from 2021.
  • Graphene & Solar Technologies Ltd annual Interest Expense for 2021 was $151K, a 310% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $35.8K $12.7K +$7.67K +153% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-24
Q4 2023 $28.2K $10K +$4.92K +96.1% Oct 1, 2023 Dec 31, 2023 10-Q 2024-03-27
Q3 2023 $23.2K $7.74K +$2.8K +56.6% Jul 1, 2023 Sep 30, 2023 10-K 2024-01-16
Q2 2023 $20.5K $5.38K +$484 +9.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-09-13
Q1 2023 $20K $5.02K +$187 +3.87% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-24
Q4 2022 $19.8K $5.11K -$15.5K -75.2% Oct 1, 2022 Dec 31, 2022 10-Q 2024-03-27
Q3 2022 $35.3K $4.94K -$17.2K -77.6% Jul 1, 2022 Sep 30, 2022 10-K 2024-01-16
Q2 2022 $52.4K $4.89K -$94.4K -95.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-09-13
Q1 2022 $147K $4.84K -$10.7K -68.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-08-04
Q4 2021 $158K $20.6K +$6.32K +44.2% Oct 1, 2021 Dec 31, 2021 10-Q 2023-06-29
Q3 2021 $151K $22.1K +$21.1K +2016% Jul 1, 2021 Sep 30, 2021 10-K 2023-04-12
Q2 2021 $130K $99.3K +$85.9K +644% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-18
Q1 2021 $44.2K $15.6K +$472 +3.13% Jan 1, 2021 Mar 31, 2021 10-Q 2022-08-04
Q4 2020 $43.7K $14.3K +$6.91K +93.8% Oct 1, 2020 Dec 31, 2020 10-Q 2022-07-29
Q3 2020 $36.8K $1.05K -$3.87K -78.7% Jul 1, 2020 Sep 30, 2020 10-K 2022-05-24
Q2 2020 $40.7K $13.3K -$7.34K -35.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-02
Q1 2020 $48K $15.1K -$27.7K -64.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-27
Q4 2019 $75.7K $7.37K -$395 -5.09% Oct 1, 2019 Dec 31, 2019 10-Q 2021-03-23
Q3 2019 $76.1K $4.91K Jul 1, 2019 Sep 30, 2019 10-K 2021-02-17
Q2 2019 $20.7K +$25.6K Apr 1, 2019 Jun 30, 2019 10-Q 2020-09-08
Q1 2019 $42.8K Jan 1, 2019 Mar 31, 2019 10-Q 2020-07-16
Q4 2018 $7.76K Oct 1, 2018 Dec 31, 2018 10-Q 2020-07-07
Q2 2018 -$4.9K Apr 1, 2018 Jun 30, 2018 10-Q 2019-09-12
Q3 2014 $1.46M $163K -$249K -60.4% Jul 1, 2014 Sep 30, 2014 10-K 2015-01-05
Q2 2014 $1.71M $393K -$68.8K -14.9% Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-14
Q1 2014 $1.78M $454K -$7.21K -1.56% Jan 1, 2014 Mar 31, 2014 10-Q/A 2014-05-19
Q4 2013 $1.78M $448K -$80.3K -15.2% Oct 1, 2013 Dec 31, 2013 10-Q 2014-02-13
Q3 2013 $1.86M $412K +$32.2K +8.47% Jul 1, 2013 Sep 30, 2013 10-K 2015-01-05
Q2 2013 $1.83M $462K +$162K +54.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $1.67M $461K +$215K +87.1% Jan 1, 2013 Mar 31, 2013 10-Q/A 2014-05-19
Q4 2012 $1.46M $529K +$283K +115% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-13
Q3 2012 $1.17M $380K +$170K +81.3% Jul 1, 2012 Sep 30, 2012 10-K 2014-01-03
Q2 2012 $1M $300K +$26K +9.52% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $975K $247K +$81.3K +49.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 $894K $246K +$214K +687% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-13
Q3 2011 $680K $210K +$210K Jul 1, 2011 Sep 30, 2011 10-K 2012-12-28
Q2 2011 $470K $274K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $165K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q4 2010 $31.2K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q3 2010 $0 Jul 19, 2010 Sep 30, 2010 10-K 2011-12-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.